News Focus
News Focus
icon url

JWC3

11/17/22 10:19 AM

#383804 RE: mike_dotcom #383800

It will just gap up to $10,000.00 per share when approval for prophylactic use for 500 CNS indications comes thru from FDA on DEC 2, 2022!